Induction of apoptosis in various tumor cell lines by geranylgeraniol

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1051-1057

  Ohizumi, Hidekazu ^a   Masuda, Yutaka ^a   Yoda, Madoka ^a   Hashimoto, Sachiko ^a   Aiuchi, Toshihiro ^a   Nakajo, Shigeo ^a   Sakai, Itaru ^b   Ohsawa, Shigemitsu ^b   Nakaya, Kazuyasu ^a  

^a SHOWA UNIVERSITY   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

Apoptosis; Bcl 2; Geranylgeraniol; HL 60; Leukemia cell; Tumor cell

Indexed keywords

CELL PROTEIN; DNA FRAGMENT; GERANIOL; GERANYLGERANIOL; MYC PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; DRUG EFFICACY; DRUG UPTAKE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

APOPTOSIS; DITERPENES; DNA FRAGMENTATION; GENES, MYC; HUMANS; TUMOR CELLS, CULTURED;

EID: 0030994823     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chou SH, Kaneko M, Nakaya K and Nakamura Y: Induction of differentiation of human and mouse myeloid leukemia cells by camptothecin. Biochem Biophys Res Commun 166: 160-167, 1990.
2. Kaufman SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
3. Zhang L, Nakaya K, Yoshida T and Kuroiwa Y: Induction by bufalin of differentiation of human leukemia cells HL60, U937, and MLI toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res 52: 4634-4641, 1992.
4. Sakai I, Tanaka T, Osawa S, Hashimoto S and Nakaya K: Geranylgeranylacetone used as an antiulcer agent is a potent inducer of differentiation of various human myeloid leukemia cell lines. Biochem Biophys Res Commun 191: 873-879, 1993.
5. Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T and Kizaki Y: Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim Biophys Acta 1175: 147-154, 1993.
6. Yoshida A, Ueda T and Nakamura T: DNA damage and cell killing by camptothecin and its derivatives in human leukemia HL-60 cells. Jpn J Cancer Res 84: 566-573, 1993.
7. Bertrand R, Solary E, Jenkins J and Pommier Y: Apoptosis and its modulation in human promyelocytic HL-60 cells treated with topoisomerase I and II inhibitors. Exp Cell Res 207: 388-387, 1993.
8. Nakaya K, Chou S, Kaneko M and Nakamura Y: Topoisomerase inhibitors have potent differentiation inducing activity for human and mouse myeloid leukemia cells. Jpn J Cancer Res 82: 184-191, 1991.
9. Barry MA, Behnke CA and Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins,and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
10. Jing Y, Ohizumi H, Kawazoe N, Hashimoto S, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K: Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: Association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res 85: 645-651, 1994.
11. Masuda Y, Kawazoe M, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K: Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leukemia Res 19: 549-556, 1995.
12. Martin SJ, Bradley JG and Cotter TG: HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Cli Exp Immunol 79: 448-453, 1990.
13. Evans MA and Dive C: Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53: 2133-2139, 1993.
14. Solary E, Bertrand R, Kohn KW and Pommier Y: Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81: 1359-1368, 1993.
15. Ohizumi H, Masuda Y, Nakajo S, Sakai I, Ohsawa S and Nakaya K: Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J Biochem 117: 11-13, 1995.
16. Laemmli UK: Cleavage of the head of bacteriophage T4. Nature 227: 680-685, 1970.
17. McGahon, A, Bissonnette R, Schmitt M, Cotter KM, Green DR and Cotter TG: Bcr-Abl maintains resistance of chronic myelogenous leukemia cells to apoptic cell death. Blood 83: 1179-1187, 1994.
18. Crick DC, Waechter CJ and Andres DA: Utilization of geranylgeraniol for protein isoprenylation in C6 glial cells. Biochem Biophys. Res. Commun 205: 955-961, 1994.
19. Bissonnette RP, Echeverri F, Mahboubi A, and Green DR: Apoptic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554, 1992.
20. Hockenbery D, Nunez G, Milliman C, Screiber RD and Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990. 355-961, 1994.
21. Haug JS, Goldner CM, Yazlovistkaya EM, Voziyan PA and Melnykovych G: Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: effect of phosphatidylcholine. Biochim Biophys Acta 1223: 133-140, 1994.
22. Yusugi E, Yokoyama Y, Seyama Y, Kano K, Hayashi Y and Oshima M: Dolichyl phosphate, a potent inducer of apoptosis in rat glioma C6 cells. Biochem Biophys Res Commun 216: 848-853, 1995.
23. Nakamura N, Shidoji Y, Moriwaki H and Muto Y: Apoptosis in human hepatoma cell line induced by 4,5-didehydrogeranyl-geranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-α. Biochem Biophys Res commun 219: 100-104, 1996.
24. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
25. Wolf D and Rotter V: Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82: 790-794, 1985.
26. Kelly K: The regulation and expression of c-myc in normal and malignant cells. Ann Rev Immunol 4: 317-338, 1986.
27. Askew DS, Ashmun RA, Simmons BC and Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922, 1991.
28. Alnemri ES, Fernandes TF, Haldar S, Croce CM and Litwack G: Involvement of bcl-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 52: 491-495, 1992.
29. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128, 1992.
30. Miyashita T and Reed JC: Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52: 5407-5411, 1992.
31. Tsujimoto Y: Stress-resistance conferred by high level of bcl-2α protein in human B lymphoblastoid cell. Oncogene 4: 1331-1336, 1989.
32. Sentman CL, Shuttrer JR, Hockenbery D, Kanagawa O and Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888, 1991.